Page last updated: 2024-10-17

lactic acid and Dyslipidemia

lactic acid has been researched along with Dyslipidemia in 8 studies

Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.

Research Excerpts

ExcerptRelevanceReference
"Childhood obesity is associated with insulin resistance (IR), increased levels of small dense low-density lipoprotein (sd-LDL) as well as with augmented hepatic de novo lipogenesis, which implies increased triose phosphate fluxes that may lead to increased methylglyoxal (MG) and its catabolic end product D-lactate."1.48Higher D-lactate levels are associated with higher prevalence of small dense low-density lipoprotein in obese adolescents. ( Bains, Y; Caccavello, R; Garay-Sevilla, ME; Gugliucci, A; Luevano-Contreras, C; Rodríguez-Mortera, R; Solorio-Meza, S, 2018)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rodríguez-Mortera, R1
Luevano-Contreras, C1
Solorio-Meza, S1
Caccavello, R1
Bains, Y1
Garay-Sevilla, ME1
Gugliucci, A1
Kobayashi, M1
Egusa, S1
Fukuda, M1
Nakamura, F1
Ishida, Y1
Sawada, D1
Ashida, N1
Sugawara, T1
Sakai, M1
Goto, T1
Kawada, T1
Fujiwara, S1
Banjoko, IO1
Adeyanju, MM1
Ademuyiwa, O1
Adebawo, OO1
Olalere, RA1
Kolawole, MO1
Adegbola, IA1
Adesanmi, TA1
Oladunjoye, TO1
Ogunnowo, AA1
Shorinola, AA1
Daropale, O1
Babatope, EB1
Osibogun, AO1
Ogunfowokan, DT1
Jentegbe, TA1
Apelehin, TG1
Ogunnowo, O1
Olokodana, O1
Fetuga, FY1
Omitola, M1
Okafor, LA1
Ebohon, CL1
Ita, JO1
Disu, KA1
Ogherebe, O1
Eriobu, SU1
Bakare, AA1
Manfredi, R1
Calza, L1
Chiodo, F1
Haugaard, SB1
Chow, DC1
Day, LJ1
Souza, SA1
Shikuma, CM1
Zuurbier, CJ1
Hoek, FJ1
van Dijk, J1
Abeling, NG1
Meijers, JC1
Levels, JH1
de Jonge, E1
de Mol, BA1
Van Wezel, HB1

Reviews

1 review available for lactic acid and Dyslipidemia

ArticleYear
Toxic metabolic syndrome associated with HAART.
    Expert opinion on drug metabolism & toxicology, 2006, Volume: 2, Issue:3

    Topics: Adiponectin; Adipose Tissue; Animals; Antiretroviral Therapy, Highly Active; Bone Diseases, Metaboli

2006

Trials

1 trial available for lactic acid and Dyslipidemia

ArticleYear
Perioperative hyperinsulinaemic normoglycaemic clamp causes hypolipidaemia after coronary artery surgery.
    British journal of anaesthesia, 2008, Volume: 100, Issue:4

    Topics: Aged; Blood Glucose; Coronary Artery Bypass; Dyslipidemias; Fatty Acids, Nonesterified; Female; Gluc

2008

Other Studies

6 other studies available for lactic acid and Dyslipidemia

ArticleYear
Higher D-lactate levels are associated with higher prevalence of small dense low-density lipoprotein in obese adolescents.
    Clinical chemistry and laboratory medicine, 2018, 06-27, Volume: 56, Issue:7

    Topics: Adolescent; Biomarkers; Body Mass Index; Carotid Intima-Media Thickness; Cross-Sectional Studies; Dy

2018
Isoflavone and protein constituents of lactic acid-fermented soy milk combine to prevent dyslipidemia in rats fed a high cholesterol diet.
    Nutrients, 2014, Dec-10, Volume: 6, Issue:12

    Topics: Animals; Biomarkers; Cholesterol, Dietary; Cultured Milk Products; Diet, High-Fat; Disease Models, A

2014
Fragmented Lactic Acid Bacterial Cells Activate Peroxisome Proliferator-Activated Receptors and Ameliorate Dyslipidemia in Obese Mice.
    Journal of agricultural and food chemistry, 2016, Mar-30, Volume: 64, Issue:12

    Topics: Animals; Atherosclerosis; Dyslipidemias; Insulin Resistance; Lactic Acid; Lipoproteins, HDL; Lipopro

2016
Hypolipidemic effects of lactic acid bacteria fermented cereal in rats.
    Lipids in health and disease, 2012, Dec-11, Volume: 11

    Topics: Animals; Bifidobacterium; Diet, High-Fat; Dyslipidemias; Edible Grain; Fermentation; Food Analysis;

2012
[Hyperlactacidemia during antiretroviral therapy: frequency and clinical-therapeutic correlations].
    Le infezioni in medicina, 2006, Volume: 14, Issue:1

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Case-Control Studies; Comorbidity; Dy

2006
Metabolic complications of HIV therapy.
    IAPAC monthly, 2006, Volume: 12, Issue:9

    Topics: Acidosis, Lactic; Anti-HIV Agents; Bone Diseases; Dyslipidemias; HIV Infections; Humans; Insulin Res

2006